This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
Cynosure Receives Health Canada Authorization to Market MonaLisa Touch® for Genitourinary Syndrome of Menopause
Cynosure, Inc. announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch® for the treatment of symptoms related to Genitourinary Syndrome of Menopause (GSM),